01—Abstract
Summary
Summary of the 8-K filed May 22, 2025. Cited figures are marked; the original filing is the authoritative source.
Thermo Fisher Scientific Inc. announced a significant long-term incentive award to its Chairman, President, and CEO, Marc N.
Casper. The company's Board of Directors approved a 5-year performance-based restricted stock unit (RSU) award with a target grant date fair value of approximately $60 milliona. This award is designed to incentivize continued leadership through at least May 2030 and to drive substantial shareholder returns, specifically through outperformance in Total Shareholder Return (TSR) relative to the S&P 500.
The Board's decision was based on a thorough review, highlighting Mr. Casper's extensive track record of value creation, including quadrupling annual revenue to $43 billionb and achieving over 800% TSR during his tenure, significantly outperforming the S&P 500 Equal Weight Index. Investor feedback also underscored the importance of his continued leadership for long-term value creation. The award structure, with a 5-year cliff vesting and an additional deferred share delivery for up to 10 years post-grant, aims to ensure sustained alignment with shareholder interests.
02—Key points
Key Highlights
- CEO Marc N. Casper granted a 5-year performance-based RSU award with a target fair value of $60 million to ensure leadership continuity through at least May 2030.
- The award is directly tied to Thermo Fisher's Total Shareholder Return (TSR) performance relative to the S&P 500 over a performance period ending December 31, 2029.
- Payouts are tiered: target achievement at the 50th percentile of S&P 500 TSR, 125% of target for 75th percentile or higher, and a 50% reduction for performance below the 25th percentile.
- Shares earned will vest on May 21, 2030, with actual delivery deferred in equal tranches on the 8th, 9th, and 10th anniversaries of the grant date to promote long-term alignment.
- The Board cited Mr. Casper's proven track record, including revenue growth from $10 billion to $43 billion and over 800% TSR during his tenure, as key reasons for the award.
- Investor feedback emphasizing the importance of executive leadership continuity for long-term shareholder value was a significant factor in the decision.
- The performance-based RSU grant is non-recurring and distinct from Mr. Casper's regular annual compensation.
03—Questions
Frequently Asked Questions
What is the main purpose of the new award granted to CEO Marc N. Casper?
The primary purpose of the award is to secure Mr. Casper's continued leadership through at least May 2030 and to strongly incentivize him to drive substantial long-term shareholder returns, specifically through outperforming the S&P 500 in Total Shareholder Return (TSR).
How is the CEO's performance measured for this award?
The award is performance-based and contingent on Thermo Fisher's TSR relative to the S&P 500 over a specific performance period. Achievement is tiered, with different payout percentages based on where the company's TSR ranks within the S&P 500 peer group.
When will Mr. Casper receive the shares from this award?
The performance-based restricted stock units will cliff vest on May 21, 2030, provided Mr. Casper remains CEO or Executive Chairman. However, the delivery of any earned shares is further deferred, with equal tranches delivered on the 8th, 9th, and 10th anniversaries following the grant date, ensuring a long-term alignment with shareholders.
Is this award part of Mr. Casper's regular compensation?
No, this performance-based restricted stock unit grant is explicitly stated as non-recurring and is not part of Mr. Casper's regular annual compensation. It is a special long-term incentive award.
04—Continue